Evaluasi Penggunaan Obat Antihipertensi pada Pasien Hipertensi Geriatri di Klinik Pratama Annisa Semarang
Evaluation of Antihypertensive Drugs Usage in Geriatrics Hypertension Patients at the Annisa Pratama Clinic Semarang
DOI:
https://doi.org/10.33084/jsm.v8i1.3417Keywords:
Evaluation of Drug Utilization, Geriatric, Hypertension, Antihypertensive DrugsAbstract
Hypertension is a disease characterized by an increase in systolic blood pressure of more than 140mmHg and diastolic blood pressure of more than 90 mmHg. Hypertension is called the “silent killer” because it does not directly kill the sufferer but triggers other diseases such as heart attacks, strokes, and kidney failure. This study aims to determine the rationale for using antihypertensive drugs in geriatric hypertensive patients, including the right indication, the right dose, the right drug, and the right patient at the Annisa Pratama Clinic Semarang. The type of research used is descriptive non-experimental, with retrospective data collection in the form of patient medical record data; as many as 45 patients were taken as samples were analyzed based on the standard of therapy used, namely The Eight Joint National Committee (JNC VIII). The results showed that the characteristics of most respondents were at the age of 45-54, namely 25 people (55,6%), and the most respondents with stage 2 hypertension were 40 people (88,9%). The rationale for using antihypertensive drugs at the Annisa Pratama Clinic Semarang is 100% correct indication, 91,1% correct dose, 91,1% correct drugs, and 100% correct patient. The use of antihypertensive drugs in geriatric patients is appropriate according to the standard of therapy used based on JNC VIII.
Downloads
References
Dengan Metode Atc/Ddd’, Farmaka, 14(2), pp. 19–25.
2. Florensia, A. (2016) Evaluasi Penggunaan Obat Antihipertensi Di Instalasi Rawat Inap RSUD Kota Tangerang Dengan Metode Anatomical Therapeutic Chemical/Defined Daily Dose Pada Tahun 2015. UIN Syarif Hidayatullah Jakarta.
3. Badan Penelitian Dan Pengembangan Kesehatan Kementerian Kesehatan Republik Indonesia (2013) Riset Kesehatan Dasar 2013. Jakarta.
4. World Health Organization Collaborating Centre for Drug Statistics Methodology (2013) Guidelines for ATC classification and DDD assignment. 16th edn. Oslo: Norwegian Institute of Public Health. Available at: www.whocc.no
5. Notoatmodjo, S. (2005) Promosi Kesehatan Teori dan Aplikasi, Rineka Cipta. Jakarta. doi: 10.1108/JMTM-03-2018-0075.
6. Agrina, Rini, S. S. and Hairitama, R. (2011) ‘Kepatuhan Lansia Penderita Hipertensi Dalam Pemenuhan Diet Hipertensi’, Sorot, 6(1), pp. 46–53. doi: 10.31258/sorot.6.1.2001.
7. Aryzki, S. et al. (2018) ‘Evaluasi Rasionalitas Pengobatan Hipertensi Di Puskesmas Pelambuan Banjar Masin Tahun 2017’, Jurnal Ilmiah Manuntung, 4(2), pp. 119–128. doi: 10.51352/jim.v4i2.191.
8. A, L., A, D. and D, H. (2020) ‘Evaluasi Penggunaan Obat Antihipertensi Di Puskesmas Ikur Koto Kota Padang Periode 2018’, Jurnal Human Care, 5(2), pp. 570–576.
9. Sumawa, P. M. R., Yamlean, P. V. Y. and Wullur, A. C. (2015) ‘Evaluasi Kerasionalan Penggunaan Obat Antihipertensi Pada Pasien Hipertensi Rawat Inap Di RSUP Prof. Dr. R. D. Kandou Manado Periode Januari-Juni 2014’, Pharmacon, 4(3), pp. 126–133. doi: 10.35799/pha.4.2015.8850.
10. Pahlawan, M. K., Astri, Y. and Saleh, I. (2013) ‘Penggunaan Obat Antihipertensi pada Pasien Hipertensi di Bagian Rawat Jalan RS Muhammadiyah Palembang Periode Juli 2011–Juni 2012’, Syifa’ MEDIKA, 4(1), pp. 22–35. doi: 10.32502/sm.v4i1.1415.
11. Brunton, L., Chabner, B. and Knollman, B. (2011) Goodman & Gilman’s The Pharmacological Basis of Therapeutics. 12th edn. Inc: The McGraw-Hill Companies.
Downloads
Published
How to Cite
Issue
Section
License
All rights reserved. This publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording.
